Vaccines Conferences | Immunology Conferences | Vaccines Summit 2018 | Vaccines Congress | Vaccines Meetings | Europe | USA | Middle East | Asia Pacific

Theme: Highlights of latest technologies and innovations in Vaccines and Immunization

Vaccines Summit 2018

ConferenceProgram

Renowned Speakers

Pierre A MORGON
MRGN Advisors
Switzerland

Poupak Fallahi
University of Pisa
Italy

Silvia Martina Ferrari
University of Pisa
Italy

Peter Timms
University of the Sunshine Coast
Australia

Yoshinori HAYAKAWA
Toin University of Yokohama
Japan

Md Jasim Uddin
International Centre for Diarrhoeal Disease Research
Bangladesh

Debaki R Howlader
National Institute of Cholera and Enteric Diseases
India

Keshan Zhang
Lanzhou Veterinary Research Institute
China

J Santiago Mejia
Oxford Immunotec
USA

Yanelys Morera Diaz
Center for Genetic Engineering and Biotechnology
Cuba

Vidisha Minhas
National Institute of Immunology
India

Emmanuelle Billon-Denis
Armed Forces Biomedical Research Institute
France

Pramod Jog
Dr. D. Y. Patil Medical College
India

Vaccines Summit 2018

ConferenceSeries Ltd looks forward to welcome all the participants across the world to attend "29^th International Conference on Vaccines and Immunization" during March 19-20, 2018 in London, UK. The conference highlights the theme “Highlights of latest technologies and innovations in Vaccines and Immunization”.

Following the great success of the 19^th International Conference on Vaccines and Immunization, February 20-21, 2017 Berlin, Germany, ConferenceSeries Ltd is again organizing the 29^th International Conference on Vaccines and Immunization on March 19-20, 2018 at London, UK. This will be one of the best annual Vaccines Conference with 300 Plus Attendees, to provide a forum where key vaccine stakeholders including academic researchers, public health clinicians, veterinarians, vaccine policy makers, and manufacturers can exchange ideas and collaborate. There will be opportunities for those chosen to present at the meeting to publish a manuscript based on their presentation in the Journal of Vaccines & Vaccination or its sister publication, Immunome Research. Conference series LLC organizes 1000+ Global Events inclusive of 350+ Conferences, 550+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 800+ Open access journals which contains over 25000 eminent personalities, reputed scientists as editorial board members.

Why to attend???

Vaccines Summit 2018 is aimed to give an opportunity that with scholars from around the world focused on learning about Vaccines & Immunology and its advances; this is the best opportunity to reach the largest assemblage of participants from the Vaccines & Immunology community. It provide an explicit platform for presentations, distribute information, meet with current and potential scientists, make a splash with new vaccines developments, and receive name recognition at this event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Vaccines & Immunology are hallmarks of this conference.

Target Audience:

Researchers & Scientists related to Vaccine R&D
Deans and Professors
Directors, CEOs, Presidents and Vice Presidents
University Faculty
Medical Schools/Colleges
Nursing Schools/Colleges
Associations and Societies related to Vaccine R&D
Vaccination Programme Organising Government and Non-government Organisations
Business Entrepreneurs
Medical Devices Manufacturing Companies
Vaccine Manufacturing Companies
Vaccine Developers and Investigators

Track 1: Bacterial and Viral Vaccines:

Vaccination can be defined as active immunity produced by vaccine. It is immunity and immunologic memory similar to natural infection but without risk of disease. There are two basic types of vaccines: live attenuated and inactivated. Live attenuated vaccines are produced by modifying a disease-producing virus or bacterium in a laboratory. Vaccines derived from bacterium are called as bacterial vaccine and from virus is as viral vaccine. The resulting vaccine organism retains the ability to replicate and produce immunity, but usually does not cause illness. Inactivated vaccines can be composed of either whole viruses or bacteria, or fractions of either.

Track 1: Human Vaccines against Infectious Diseases

Infectious diseases are responsible for approximately 25% of global mortality, especially in children aged younger than 5 years. Much of the burden of infectious diseases could be alleviated if appropriate mechanisms could be put in place to ensure access for all children to basic vaccines, regardless of geographical location or economic status. In addition, new safe and effective vaccines should be developed for a variety of infections against which no effective preventive intervention measure is either available or practical. The public, private, and philanthropic sectors need to join forces to ensure that these new or improved vaccines are fully developed and become accessible to the populations in need as quickly as possible.

5th International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4th World Conferences on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; International Conferences on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 6^th World Conferences on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 13^th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 6^th Euro-Global Conferences on Infectious Diseases, September 7-9, 2017 Paris, France; 3rd International Conferences on Influenza and Zoonotic Diseases, August 21-22, 2017 Birmingham, UK; 18^thInternational Conferences on Infectious Diseases, March 1-4, 2018 Buenos, Argentina; The European Conferences of Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; ICID 2018; 20th International Conferences on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Twelfth Annual Conferences on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; 30^th Annual Conferences on Infectious Diseases in Children, November 18-19, 2017 New York, USA; Conferences on Infectious Diseases: Adult Issues in the Outpatient and Inpatient Settings, April 02-06, 2018 Florida, USA; ID Week 2017 Infectious Diseases Society of America Conferences (IDSA), October 4-7, 2017 California, USA; 10^th World Conferences of the World Society of Pediatric Infectious Diseases (WSPID), December 2-5, 2017 Shenzhen, China

Related Societies:

Europe:

European Society for Immunodeficiency; French Society of Immunology ; Immunology of Diabetes Society; Deutsche Gesellschaft für Immunologie

USA:

American Academy of Paediatrics (AAP); American College Health Association (ACHA); Association of Immunization Managers (AIM); Association for Professionals in Infection Control and Epidemiology (APIC)

Asia and Middle-East:

Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAAACI); Asia Pacific Association of Pediatric Allergy, Respirology and Immunology (APAPARI); Commonwealth of Independent States Society of Allergology and Immunology (CIS Society)

Track 2: Cancer, Malaria & TB Vaccines

Therapeutic cancer vaccines are administrated to cancer patients to eradicate cancer cells through strengthening patient's own immune responses. The various immune effector mechanisms of therapeutic vaccination i.e. it specifically attack and destroy cancer cells and spare normal cells. Thus cancer vaccines may be utilized to inhibit further growth of advanced cancers and/or relapsed tumours that are refractory to conventional therapies, such as surgery, radiation therapy and chemotherapy. Despite of many decades of intense research and development, there is no commercially available malaria vaccine till today. RTS,S/AS01 is the most advanced vaccines candidate against the most deadly human malaria, P. falciparum. More than 20 other vaccine constructed are currently in clinical trials or are in advanced preclinical development. BCG is the only available TB vaccines. But, BCG is partially effective as it provides protection only against severe forms of paediatric TB, not completely protective against infants and adult pulmonary TB. Therefore there is an urgent need for new, safe and effective vaccines that prevent against all forms of TB.

28^th Euro Conferences on Cancer Science & Therapy, August 09-10, 2018 Madrid, Spain; 27^th International Conferences on Oncology Research & Cancer Stem Cells, May 10-12, 2018 Frankfurt, Germany; 9^th International Conferences on Leukemia and Hematologic Oncology, October 05-06,2017 London, UK; 2^nd International Conferences on Epigenetics & Chromatin, November 06-08, 2017 Frankfurt, Germany; 9^th World Biomarkers Conferences, December 07-08, 2017 Madrid, Spain; Global Conferences on Oncology & Cancer, March 14-16, 2018 Singapore;11^th European Breast Cancer Conferences (EBCC-11), March 21-23, 2018 Barcelona, Spain; 35^th Annual Miami Breast Cancer Conferences, March 8-11, 2018 Florida, USA; A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments Conferences, February 1- 3, 2018, Amsterdam, Netherlands; Radiation Break-through: from DNA damage responses to precision cancer therapy Conferences, March 12 – 14, 2018 Oxford, UK; Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 4 - 6 June 2018; 25^th Biennial Conferences of the European Association for Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; World Cancer Conferences, October 1-4 2018 Kuala Lumpur, Malaysia; Conferences on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada; ESMO 2017 Conferences-Integrating science into oncology for a better patient outcome, September 08-12 2017 Madrid, Spain

Related Societies:

Europe:

European Academy of Paediatrics; European Malaria Foundation (e-malaria Foundation); European Malaria Vaccine Development (EUROMALVAC); European malaria Vaccine Initiative (EMVI)

USA:

Autism Science Foundation (ASF); Childhood Influenza Immunization Coalition (CIIC); Edward Jenner Vaccine Society; Global Polio Eradication Initiative

Asia and Middle-East:

Lebanese Society of Allergy and Immunology; Moldavian Society of Allergology & Immunology; Moroccan Society of Allergology and Clinical Immunology

Track 3: HIV Vaccines

An AIDS vaccine does not yet exist, but efforts to develop a vaccine against HIV, the virus that causes AIDS, have been underway for many years. An HIV vaccine could be effective in either of two ways. A preventive vaccine would stop HIV infection occurring altogether, whereas a therapeutic vaccine would not stop infection, but would prevent or delay illness in people who do become infected, and might also reduce the risk of them transmitting the virus to other people. Although a preventive vaccine would be ideal, therapeutic vaccines would also be highly beneficial. The basic idea behind all HIV vaccines is to encourage the human immune system to fight HIV.

6^th World Conferences on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 29^thInternational Conferences on Vaccines and Immunization, March 19-20, 2018 London, UK ; 5^th International Conferences on HIV/AIDS, STDs and STIs, November 13-14, 2017 Las Vegas, Nevada, USA; 7^th Asia Pacific STD and Infectious Diseases Conferences, October 23-25, 2017 Osaka, Japan; 9th European Immunology Conferences, June 14-16, 2018 Rome, Italy; 2^nd International Conferences on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; 11^thInternational Conferences on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; 22^nd International AIDS Conferences (AIDS 2018) July 23-27 2018 Amsterdam, Netherlands; CHA 2018; 20^thInternational Conferences on HIV and AIDS, May 14 - 15, 2018 London, UK; The annual Conferences on Retroviruses and Opportunistic Infections (CROI), March 4 -7, 2018 Massachusetts, USA; 12^th Annual ACTHIV, April 5 - 7, 2018, Chicago, USA; 20^th Bangkok International Symposium on HIV Medicine 2018, January 17 - 19, 2018, Bangkok, Thailand; 2^ndInternational Conferences on Healthy Living for HIV Infected Individuals, September 01-02, 2017 Barcelona, Spain; 21^stAnnual United States Conferences on AIDS (USCA), September 07-09, 2017 Washington, DC, USA; European Conferences on Healthy Living with HIV, September 15-16, 2017 Barcelona, Spain; 16^th European AIDS Conferences, October 25-28, 2017 Mila, Italy; Australasian AIDS Conferences 2017, November 06-08, 2017 Canberra, Australia; ICASA 2017: International Conferences on AIDS and STIs in Africa (ICASA), December 04-09, 2017; Côte d’Ivoire, West Africa

Related Societies:

Europe:

British Society for Immunology; Microbiology Society; Society for Applied Microbiology; European Society of Clinical Microbiology and Infectious Diseases

USA:

The Federation of Clinical Immunology Societies; The American Association of Immunologists; American Society for Microbiology; Colombian Allergy, Asthma and Immunology Association; Canadian Society for Immunology

Asia and Middle-East:

Indian society of Allergy, Asthma and Clinical Immunology; Australasian Society of Clinical Immunology and Allergy; Bangladesh Society of Allergy and Immunology

Track 4: Immunizations & Bioterrorism

Bioweapons threat could include the deliberate release of a biological agent by attackers that causes one or more variety of different diseases. The use of effective vaccines would likely to protect lives and limit disease spread in a biological weapons emergency. Licensed vaccines are currently available for a few threats, such as anthrax and smallpox, and research is underway to develop and produce vaccines for other threats, such as tularaemia, Ebola virus, and Marburg virus. Many bioweapon disease threats, however, lack a corresponding vaccine, and for those that do, significant challenges exist to their successful use in an emergency situation.

29^th International Conferences on Vaccines and Immunization, March 19-20, 2018 London, UK; 9th Molecular Immunology & Immunogenetics Conferences, March 08-09, 2018 London, UK; 9^th European Immunology Conferences, June 14-16, 2018 Rome, Italy; 2^nd International Conferences on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; 11^th International Conferences on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; 5^th International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; International Conferences on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 6^thWorld Conferences on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 4^th ESCMID Conferences on Vaccines, September 8-10, 2017 Dubrovnik, Croatia; 2017 International Society for Vaccines (ISV) Annual Conferences, October 5-7, 2017 Paris, France; Vaccines Research & Development Conferences 2017, November 20-22, 2017, Valencia, Spain; 2^nd Global Conferences on Vaccines Research, March 19-20, 2018 London, UK; World Vaccine Conferences Washington 2018, April 3-5, 2018 Washington DC, USA; Global Conferences on Vaccines and Vaccination Techniques, April 16-18, 2018, Dubai, UAE; 4^th Global Conferences on Virology and Vaccines, April 19-21, 2018 Valencia, Spain; 48^th National Immunization Conferences, May 15-17, 2018 Atlanta, USA; Vaccines Technology Conferences VII, June 17-22, 2018 Quebec, Canada; HIV Research for prevention Conferences (HIVR4P) October 21-25, 2018 Madrid, Spain

Related Societies:

Europe:

Albanian Society of Allergology and Clinical Immunology; Austrian Society of Allergology and Immunology; Belgian Society of Allergy and Clinical Immunology; British Society of Allergy and Clinical Immunology

USA:

Argentine Association of Allergy and Immunology; Argentine Society of Allergy and Immunology; Brazilian Society of Allergy and Immunology; Chilean Society of Allergy and Immunology

Asia and Middle-East:

Allergy & Immunology Society of Sri Lanka; Allergy and Clinical Immunology Society of Singapore; Allergy and Immunology Society of Thailand

Track 5: Combination and Conjugate Vaccines

Increasingly, more diseases are becoming vaccine preventable, but maintaining community and provider acceptance demands that the number of injections doesn’t increase. Combination conjugate vaccines represent an inevitable and important advance. This paper reviews the efficacy and safety of combination conjugate vaccines, including immunological mechanisms underlying interactions among vaccine epitopes, the role of immunological memory, and correlates of immunity. Specific attention is given to the experience with combination vaccines against each of Haemophilus influenzae type b, Streptococcus pneumoniae and Neisseria meningitidis. The implications of these findings for different communities are discussed, key areas for further research identified and implications for post-licensure monitoring addressed.

6^th Euro-Global Conferences on Infectious Diseases, September 7-9, 2017 Paris, France; 5^th International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4^th World Conferences on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; International Conferences on Emerging Infectious Diseases, 31^st August-1^st September 2018 Zurich, Switzerland; 6^th World Conferences on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 13^th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 7^th Asia Pacific STD and Infectious Diseases Conferences, October 23-25, 2017 Osaka, Japan; 3^rd International Conferences on Flu and Emerging Infectious Diseases, November 06-07, 2017 Las Vegas, Nevada, USA; Vaccines Conferences; 18^th International Conferences on Infectious Diseases, March 1-4, 2018 Buenos, Argentina; The European Conferences of Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; ICID 2018 : 20^th International Conferences on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Twelfth Annual Conferences on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; 30^th Annual Conferences on Infectious Diseases in Children, November 18-19, 2017 New York, USA; Conferences on Infectious Diseases: Adult Issues in the Outpatient and Inpatient Settings, April 02-06, 2018 Florida, USA; ID Week 2017 Infectious Diseases Society of America Conferences(IDSA), October 4-7, 2017 California, USA; 10^th World Conferences of the World Society of Pediatric Infectious Diseases(WSPID), December 2-5, 2017 Shenzhen, China

Related Societies:

Europe:

Swiss Society for Microbiology; Federation of European Microbiological Societies; International Society of Vaccines; International Union of Immunological Society

USA:

Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy, Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clincial Immunology

Asia and Middle-East:

Indonesian Society of Allergy and Immunology; Korean Academy of Asthma, Allergy and Clinical Immunology; Malaysian Society of Allergy and Immunology

Track 6: DNA & Synthetic Vaccines

Scientists take many approaches to designing vaccines against a microbe. These choices are typically based on fundamental information about the microbe, such as how it infects cells and how the immune system responds to it, as well as practical considerations, such as regions of the world where the vaccine would be used. A DNA vaccine against a microbe would evoke a strong antibody response to the free-floating antigen secreted by cells, and the vaccine also would stimulate a strong cellular response against the microbial antigens displayed on cell surfaces. The DNA vaccine couldn’t cause the disease because it wouldn’t contain the microbe, just copies of a few of its genes. In addition, DNA vaccines are relatively easy and inexpensive to design and produce. Inactivated vaccines can be composed of either whole viruses or bacteria, or fractions of either. Fractional vaccines are either protein-based or polysaccharide-based.

3^rd International Conferences on Reproductive Health and Medicine, May 21-22, 2018 Vienna, Austria; Vaccines Conferences USA 2018; 4th Annual Conferences and Medicare Expo on Trauma & Critical Care, February 22-23, 2018 Paris, France; 47th Global Nursing & Healthcare Conferences, March 01-03, 2018 London, UK; 7th World Conferences on Breast Cancer, May 10-11, 2018 Frankfurt, Germany; Vaccines Conferences Asia 2018; 13^th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 27th International Conferences on Oncology Research & Cancer Stem Cells, May 10-12, 2018 Frankfurt, Germany; Vaccines Conferences Middle East 2018; 28^th Euro Conferences on Cancer Science & Therapy, August 09-10, 2018 Madrid, Spain; 11^th European Breast Cancer Conferences (EBCC-11), March 21-23, 2018 Barcelona, Spain; Vaccines Conferences; 35^thAnnual Miami Breast Cancer Conferences, March 8-11, 2018 Florida, USA; Vaccines Conferences Canada 2018; A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments Conferences, February 1- 3, 2018, Amsterdam, Netherlands; Radiation Break-through: from DNA damage responses to precision cancer therapy, March 12 – 14, 2018 Oxford, UK; Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 4 - 6 June 2018; 25^th Biennial Conferences of the European Association for Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; Vaccines Conferences Australia; World Cancer Conferences, October 1-4 2018 Kuala Lumpur, Malaysia; Conferences on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada; ESMO 2017 Conferences-Integrating science into oncology for a better patient outcome, September 08-12 2017 Madrid, Spain; 37^th Annual Pregnancy Conferences, January 23 - 28, 2017 Las Vegas, USA

Related Societies:

Europe:

Croatian Society of Allergology and Clinical Immunology; Czech Society of Allergology and Clinical Immunology; Finnish Society of Allergology and Clinical Immunology; French Society of Allergology and Clinical Immunology

USA:

Panamanian Association of Allergology and Clinical Immunology; Paraguayan Society of Allergy, Asthma, and Immunology; Peruvian Society of Allergy and Immunology; Venezuelan Society of Allergy, Asthma and Immunology

Asia and Middle-East:

Philippine Society of Allergy, Asthma and Immunology; Taiwan Academy of Pediatric Allergy Asthma Immunology; Vietnam Association of Allergy, Asthma and Clinical Immunology

Track 7: Travel & Edible Vaccines

Travel vaccines are recommended to provide protection against diseases endemic to the country of origin or of destination. They are intended to protect travellers and to prevent disease spread within and between countries. There is no single vaccination schedule that fits all travellers. Each schedule must be individualized according to the traveller’s previous immunizations, health status and risk factors, the countries to be visited, the type and duration of travel, and the amount of time available before departure.

Edible vaccines hold great promise as a cost-effective, easy-to-administer, easy-to-store, fail-safe and sociocultural readily acceptable vaccine delivery system, especially for the poor developing countries. It involves introduction of selected desired genes into plants and then inducing these altered plants to manufacture the encoded proteins.

10^th International Virology Conferences and Expo, July 02-04, 2018 Vienna, Austria; 8^th Global Conferences on Microbiology & Infectious Diseases, February 22-23, 2018 Paris, France; Vaccines Conferences USA 2018; 16^th International Pharmaceutical Microbiology and Biotechnology Conferences, May 21-23, 2018 Vienna, Austria; 4^th World Conferences and Expo on Applied Microbiology, November 29-December 01, 2017 Madrid, Spain; Vaccines Conferences Asia 2018; 8^th Clinical Microbiology Conferences, October 26-28, 2017 Paris, France; 46^th World Conferences on Microbiology, September 18-19, 2017 Dublin, Ireland; 13th World Conferences on Healthcare & Technologies, June 14-15, 2018 Dublin, Ireland; British Society for Immunology Conferences 2017, December 04-07, 2017 Brighton, UK; Vaccines Conferences Middle East 2018; Keystone Symposium: Conferences on Cancer Immunotherapy: Combinations, March 23-27, 2018 Montreal, Canada; Vaccines Conferences; Keystone Symposium on HIV and Co-infections: Pathogenesis, Inflammation and Persistence, April 15-19 2018 Whistler, Canada; Vaccines Conferences Canada 2018; Immunochemistry and Immunobiology Conferences, June 10-15, 2018 West Dover, USA; Mechanisms in Immunity and Autoimmunity Conferences, June 17-21, 2018 Dresden, Germany; Gordon Research Conferences: Cell Death, August 05–10, 2018 Newry, USA; 25^th Biennial Conferences of the European Association for Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; World Cancer Conferences, October 1-4 2018 Kuala Lumpur, Malaysia; Vaccines Conferences Australia; ESMO 2017 Conferences-Integrating science into Oncology Conference for a better patient outcome, September 08-12 2017 Madrid, Spain; 37^th Annual Pregnancy Conferences, January 23 - 28, 2017 Las Vegas, USA

Related Societies:

Europe:

Slovenian Association for Allergology & Clinical Immunology; Spanish Society of Allergology and Clinical Immunology; European Federation for Immunogenetics; European Macrophage and Dendritic Cell Society

USA:

American Association of Immunologists; American Association of Pharmaceutical Scientists; American Association of Veterinary Immunologists; American Society for Histocompatibility and Immunogenetics

Asia and Middle-East:

Israel Association of Allergy and Clinical Immunology; Jordanian Society for Allergy and Clinical Immunology; Kuwait Society of Allergy & Clinical Immunology; Japanese Society for Immunology; Singaporean Society For Immunology; Australasian Society of Clinical Immunology and Allergy

Track 8: Paediatric Vaccination

Immunization against diseases such as Polio, Tetanus, Diphtheria, and Pertussis saves the lives of approximately three million children each year. Immunization also prevents many more millions from suffering debilitating illness and lifelong disability. Globally, approximately 132 million babies need to be fully immunized each year. In order to meet this need, immunization systems must have adequate resources, trained and motivated staff, and ample vaccines and syringe supplies.

20^th International Conferences on Neonatology and Perinatology, December 04-06, 2017 Madrid, Spain; Vaccines Conferences USA 2018; 15^thInternational Conferences on Pediatrics and Pediatric Cardiology, February 19-20, 2018 Paris, France; 20^thInternational Conferences on Pediatrics Primary Care, September 03-04, 2018 Zurich, Switzerland; 3^rd International Conferences on Pediatric Surgery, May 07-08, 2018 Frankfurt, Germany; Vaccines Conferences Asia 2018; 14^th International Conferences on Clinical Pediatrics, June 14-16, 2018 Rome, Italy; 17^th Annual Conferences on Pediatrics & Adolescent Medicine, July 09-10, 2018 Sydney, Australia; Vaccines Conferences; 21^st Annual Conferences on Neonatology & Pediatrics, May 30-31, 2018 Osaka, Japan; Vaccines Conferences Middle East 2018; 39^th National Conferences on Pediatric Health Care National Association of Pediatric Nurse Practitioners, March 19-22, 2018 Chicago, USA; 4^th ESCMID Conferences on Vaccines, September 8-10, 2017 Dubrovnik, Croatia; Vaccines Conferences Canada 2018; 2017 International Society for Vaccines (ISV) Annual Conferences, October 5-7, 2017 Paris, France; Vaccines R & D Conferences 2017, November 20-22, 2017, Valencia, Spain; 2^nd Global Conferences and Expo on Vaccines Research, March 19-20, 2018 London, UK; Vaccines Conferences Australia; World Vaccine Conferences Washington 2018, April 3-5, 2018 Washington DC, USA; Conferences on Vaccines and Vaccination Techniques, April 16-18, 2018, Dubai, UAE; 4^th Global Conferences Virology and Vaccines, April 19-21, 2018 Valencia, Spain; 48th National Immunization Conferences, May 15-17, 2018 Atlanta, USA; Vaccine Technology VII, June 17-22, 2018 Quebec, Canada; HIV Research for prevention Conferences (HIVR4P) October 21-25, 2018 Madrid, Spain

Related Societies:

Europe:

European Society for Immunodeficiency; French Society of Immunology ; Immunology of Diabetes Society; Deutsche Gesellschaft für Immunologie

USA:

Asia and Middle-East:

Track 9: Vaccines for Immune Mediated Diseases

Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immune-modulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for Hepatitis B, Influenza and Pneumococcal vaccination.

29^th International Conferences on Vaccines and Immunization, March 19-20, 2018 London, UK; Vaccines Conferences USA 2018; 9th Molecular Immunology & Immunogenetics Conferences, March 08-09, 2018 London, UK; 9^th European Immunology Conferences, June 14-16, 2018 Rome, Italy; 2^nd International Conferences on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; Vaccines Conferences Asia 2018; 11^th International Conferences on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; 5^th International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; Vaccines Conferences; International Conferences on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; Vaccines Conferences Middle East 2018; 6^thWorld Conferences on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 4^th ESCMID Conferences on Vaccines, September 8-10, 2017 Dubrovnik, Croatia; 2017 International Society for Vaccines (ISV) Annual Conferences, October 5-7, 2017 Paris, France; Vaccines Conferences Canada 2018; Vaccines Research & Development Conferences 2017, November 20-22, 2017, Valencia, Spain; 2^nd Global Conferences on Vaccines Research, March 19-20, 2018 London, UK; World Vaccine Conferences Washington 2018, April 3-5, 2018 Washington DC, USA; Global Conferences on Vaccines and Vaccination Techniques, April 16-18, 2018, Dubai, UAE; 4^th Global Conferences on Virology and Vaccines, April 19-21, 2018 Valencia, Spain; Vaccines Conferences Australia; 48^th National Immunization Conferences, May 15-17, 2018 Atlanta, USA; Vaccines Technology Conferences VII, June 17-22, 2018 Quebec, Canada; HIV Research for prevention Conferences (HIVR4P) October 21-25, 2018 Madrid, Spain

Related Societies:

Europe:

European Academy of Allergy and Clinical Immunology (EAACI); European Molecular Biology Laboratory (EMBL); Medical Research Council (MRC)

USA:

Hepatitis B Foundation (HBF); Infectious Diseases Society of America (IDSA); National Adult and Influenza Immunization Conferences (NAIIS); National Foundation for Infectious Diseases (NFID); Paediatrics Infectious Diseases Society (PIDS)

Asia and Middle-East:

Russian Association of Allergology and Clinical Immunology; Turkish National Society of Allergy and Clinical Immunology; Ukrainian Association of Allergologists and Clinical Immunologists

Track 10: Veterinary Vaccines

Considerable progress has been made in the production of veterinary vaccines whether live or inactivated for animal use during the past two decades with the increasing use of continuous cell lines as a substrate and adoption of the fermentor technology for antigen production. These vaccines are produced for administration to domestic animals or wild species by parenteral or oral routes according to vaccine characteristics. More recently a third generation of live veterinary rabies vaccine has been developed using recombinant technology. Depending upon the expression system these vaccines are used either parentally or orally. Oral rabies vaccines are widely used in foxes in Europe and in racoons in the USA. Trials are under way for the oral immunization of dogs in developing countries.

5th International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4th World Conferences on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; Vaccines Conferences USA 2018; International Conferences on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 6^th World Conferences on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; Vaccines Conferences Asia 2018; 13^th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 6^th Euro-Global Conferences on Infectious Diseases, September 7-9, 2017 Paris, France; 3rd International Conferences on Influenza and Zoonotic Diseases, August 21-22, 2017 Birmingham, UK; Vaccines Conferences Middle East 2018; 18^thInternational Conferences on Infectious Diseases, March 1-4, 2018 Buenos, Argentina; The European Conferences of Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; ICID 2018; 20th International Conferences on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Vaccines Conferences Canada 2018; Twelfth Annual Conferences on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; Vaccines Conferences; 30^th Annual Conferences on Infectious Diseases in Children, November 18-19, 2017 New York, USA; Conferences on Infectious Diseases: Adult Issues in the Outpatient and Inpatient Settings, April 02-06, 2018 Florida, USA; Vaccines Conferences Australia; ID Week 2017 Infectious Diseases Society of America Conferences (IDSA), October 4-7, 2017 California, USA; 10^th World Conferences of the World Society of Pediatric Infectious Diseases (WSPID), December 2-5, 2017 Shenzhen, China

Related Societies:

Europe:

British Society for Allergy and Clinical Immunology; British Society for Histocompatibility and Immunogenetics; European Federation of Immunological Societies; European Academy of Allergology and Clinical Immunology

USA:

Voices For Vaccines (VFV); National Institute of Allergy and Infectious Disease (NIAID); American Public Health Association (APHA); American Association for the Advancement of Science (AAAS); American Society for Microbiology (ASM)

Asia and Middle-East:

Australasian Society for Immunology; Australasian Society of Clinical Immunology and Allergy; Israel Association of Allergy and Clinical Immunology; Jordanian Society for Allergy and Clinical Immunology; Japanese Society for Immunology

Track 11: Fish & Poultry Vaccines

Vaccines developed for aquaculture have reduced antibiotic use in fish production. Currently, vaccines are available for some economically important bacterial and only few vaccines for viral diseases and no vaccine developed for fish parasites and fungus. Major limitations in fish vaccine developments are less understanding of fish immunology, many vaccines unlicensed, not cost effective (expensive) and stressful on administration. Research are needed to review on the present status of fish vaccination for controlling fish diseases, and shows the needs and directions for future investigations.

Vaccination plays an important part in the health management of the poultry flock. There are numerous diseases that are prevented by vaccinating the birds against them. A vaccine helps to prevent a particular disease by triggering or boosting the bird’s immune system to produce antibodies that in turn fight the invading causal organisms.

6^th Euro-Global Conferences on Infectious Diseases, September 7-9, 2017 Paris, France; Vaccines Conferences USA 2018; 5^th International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4^th World Conferences on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; International Conferences on Emerging Infectious Diseases, 31^st August-1^st September 2018 Zurich, Switzerland; Vaccines Conferences Asia 2018; 6^th World Conferences on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 13^th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; Vaccines Conferences Middle East 2018; 7^th Asia Pacific STD and Infectious Diseases Conferences, October 23-25, 2017 Osaka, Japan; 3^rd International Conferences on Flu and Emerging Infectious Diseases, November 06-07, 2017 Las Vegas, Nevada, USA; 18^th International Conferences on Infectious Diseases, March 1-4, 2018 Buenos, Argentina; Vaccines Conferences; The European Conferences of Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; Vaccines Conferences Canada 2018 ICID 2018 : 20^th International Conferences on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Twelfth Annual Conferences on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; 30^th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 New York, USA; Vaccines Conferences Australia; Conferences on Infectious Diseases: Adult Issues in the Outpatient and Inpatient Settings, April 02-06, 2018 Florida, USA; ID Week 2017 Infectious Diseases Society of America Conferences(IDSA), October 4-7, 2017 California, USA; 10^th World Conferences of the World Society of Pediatric Infectious Diseases(WSPID), December 2-5, 2017 Shenzhen, China

Related Societies:

Europe:

USA:

American Association of Immunologists; American Association of Pharmaceutical Scientists; American Association of Veterinary Immunologists; American Society for Histocompatibility and Immunogenetics

Asia and Middle-East:

Track 12: Vaccines against Drugs

Drug addiction is a serious problem worldwide. One therapy being investigated is vaccines against drugs of abuse. The antibodies elicited against the drug can take up the drug and prevent it from reaching the reward centres in the brain. Few such vaccines have entered clinical trials, but research is going on apace. Many studies are very promising and more clinical trials should be coming out in the near future.

6^th World Conferences on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 29^thInternational Conferences on Vaccines and Immunization, March 19-20, 2018 London, UK ; Vaccines Conferences USA 2018; 5^th International Conferences on HIV/AIDS, STDs and STIs, November 13-14, 2017 Las Vegas, Nevada, USA; 7^th Asia Pacific STD and Infectious Diseases Conferences, October 23-25, 2017 Osaka, Japan; 9th European Immunology Conferences, June 14-16, 2018 Rome, Italy; 2^nd International Conferences on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; Vaccines Conferences Asia 2018; 11^thInternational Conferences on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; 22^nd International AIDS Conferences (AIDS 2018) July 23-27 2018 Amsterdam, Netherlands; CHA 2018; 20^thInternational Conferences on HIV and AIDS, May 14 - 15, 2018 London, UK; Vaccines Conferences Middle East 2018; The annual Conferences on Retroviruses and Opportunistic Infections (CROI), March 4 -7, 2018 Massachusetts, USA; 12^th Annual ACTHIV, April 5 - 7, 2018, Chicago, USA; 20^th Bangkok International Symposium on HIV Medicine 2018, January 17 - 19, 2018, Bangkok, Thailand; 2^ndInternational Conferences on Healthy Living for HIV Infected Individuals, September 01-02, 2017 Barcelona, Spain; Vaccines Conferences Canada 2018; Vaccines Conferences; 21^stAnnual United States Conferences on AIDS (USCA), September 07-09, 2017 Washington, DC, USA; European Conferences on Healthy Living with HIV, September 15-16, 2017 Barcelona, Spain; Vaccines Conferences Australia; 16^th European AIDS Conferences, October 25-28, 2017 Mila, Italy; Australasian AIDS Conferences 2017, November 06-08, 2017 Canberra, Australia; ICASA 2017: International Conferences on AIDS and STIs in Africa (ICASA), December 04-09, 2017; Côte d’Ivoire, West Africa

Related Societies:

Europe:

European Society for Paediatric Infectious Diseases; European Union Geriatric Medicine Society; European Federation of Immunological Societies; European Academy of Allergy and Clinical Immunology

USA:

The Anti-Vaccination Society of America; Infectious Diseases Society of America; Association of Immunization Managers; Clinical Immunology Society

Asia and Middle-East:

Japanese Society for Immunology; Singaporean Society for Immunology; Australasian Society of Clinical Immunology and Allergy

Track 13: Vaccines & Autism

Vaccinations may be one of the triggers for autism. Substantial data demonstrate immune abnormality in many autistic children consistent with impaired resistance to infection, activation of inflammatory response, and autoimmunity. Impaired resistance may predispose to vaccine injury in autism. A mercurial preservative in childhood vaccines, thimerosal, may cause direct neurotoxic, immune-depressive, and autoimmune injury and contribute to early-onset and regressed autism. Live viruses in measles, mumps, and rubella (MMR) may result in chronic infection of the gut and trigger regressed autism. Thimerosal injection may potentiate MMR injury.

10^th International Virology Conferences and Expo, July 02-04, 2018 Vienna, Austria; Vaccines Conferences USA 2018; 8^th Global Conferences on Microbiology & Infectious Diseases, February 22-23, 2018 Paris, France; 16^th International Pharmaceutical Microbiology and Biotechnology Conferences, May 21-23, 2018 Vienna, Austria; Vaccines Conferences Asia 2018; 4^th World Conferences and Expo on Applied Microbiology, November 29-December 01, 2017 Madrid, Spain; 8^th Clinical Microbiology Conferences, October 26-28, 2017 Paris, France; 46^th World Conferences on Microbiology, September 18-19, 2017 Dublin, Ireland; Vaccines Conferences Middle East 2018; 13th World Conferences on Healthcare & Technologies, June 14-15, 2018 Dublin, Ireland; British Society for Immunology Conferences 2017, December 04-07, 2017 Brighton, UK; Keystone Symposium: Conferences on Cancer Immunotherapy: Combinations, March 23-27, 2018 Montreal, Canada; Vaccines Conferences; Keystone Symposium on HIV and Co-infections: Pathogenesis, Inflammation and Persistence, April 15-19 2018 Whistler, Canada; Vaccines Conferences Canada 2018; Immunochemistry and Immunobiology Conferences, June 10-15, 2018 West Dover, USA; Mechanisms in Immunity and Autoimmunity Conferences, June 17-21, 2018 Dresden, Germany; Gordon Research Conferences: Cell Death, August 05–10, 2018 Newry, USA; 25^th Biennial Conferences of the European Association for Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; Vaccines Conferences Australia; World Cancer Conferences, October 1-4 2018 Kuala Lumpur, Malaysia; ESMO 2017 Conferences-Integrating science into oncology Cnference for a better patient outcome, September 08-12 2017 Madrid, Spain; 37^th Annual Pregnancy Conferences, January 23 - 28, 2017 Las Vegas, USA

Related Societies:

Europe:

British Society for Immunology; Microbiology Society; Society for Applied Microbiology; European Society of Clinical Microbiology and Infectious Diseases

USA:

Asia and Middle-East:

Indian society of Allergy, Asthma and Clinical Immunology; Australasian Society of Clinical Immunology and Allergy; Bangladesh Society of Allergy and Immunology

Track 14: Vaccine Safety and Efficacy

Vaccine efficacy refers to the ability of vaccines to bring about the intended beneficial effects on vaccinated individuals in a defined population under ideal conditions of use. The potential benefits of an effective vaccine – e.g. promotion of health and well-being, and protection from illness and its physical, psychological and socioeconomic consequences must be weighed against the potential risk of an adverse event following immunization (AEFI) with that vaccine. Vaccine-associated risk is the probability of an adverse or unwanted outcome occurring, and the severity of the resulting harm to the health of vaccinated individuals in a defined population following immunization with a vaccine under ideal conditions of use.

6^th Euro-Global Conferences on Infectious Diseases, September 7-9, 2017 Paris, France; 5^th International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; Vaccines Conferences USA 2018; 4^th World Conferences on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; International Conferences on Emerging Infectious Diseases, 31^st August-1^st September 2018 Zurich, Switzerland; Vaccines Conferences Asia 2018; 6^th World Conferences on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 13^th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 7^th Asia Pacific STD and Infectious Diseases Conferences, October 23-25, 2017 Osaka, Japan; 3^rd International Conferences on Flu and Emerging Infectious Diseases, November 06-07, 2017 Las Vegas, Nevada, USA; Vaccines Conferences Middle East 2018; 18^th International Conferences on Infectious Diseases, March 1-4, 2018 Buenos, Argentina; The European Conferences of Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; Vaccines Conferences; ICID 2018 : 20^th International Conferences on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Vaccines Conferences Canada 2018; Twelfth Annual Conferences on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; 30^th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 New York, USA; Conferences on Infectious Diseases: Adult Issues in the Outpatient and Inpatient Settings, April 02-06, 2018 Florida, USA; ID Week 2017 Infectious Diseases Society of America Conferences(IDSA), October 4-7, 2017 California, USA; Vaccines Conferences Australia; 10^th World Conferences of the World Society of Pediatric Infectious Diseases(WSPID), December 2-5, 2017 Shenzhen, China

Related Societies:

Europe:

European Academy of Paediatrics; European Malaria Foundation (e-malaria Foundation); European Malaria Vaccine Development (EUROMALVAC); European malaria Vaccine Initiative (EMVI)

USA:

Autism Science Foundation (ASF); Childhood Influenza Immunization Coalition (CIIC); Edward Jenner Vaccine Society; Global Polio Eradication Initiative

Asia and Middle-East:

Lebanese Society of Allergy and Immunology; Moldavian Society of Allergology & Immunology; Moroccan Society of Allergology and Clinical Immunology

Track 15: Geriatric Immunization

As we get older, our immune system tends to weaken over time, putting us at higher risk for certain diseases. This is why, in addition to seasonal flu (influenza) vaccine and Td or Tdap vaccine (tetanus, diphtheria, and pertussis), the adults 60 years or older should take Pneumococcal vaccines, which protect against pneumococcal disease, including infections in the lungs and bloodstream (also recommended for adults younger than 65 years who have certain chronic health conditions) and Zoster vaccine, which protects against shingles.

28^th Euro Conferences on Cancer Science & Therapy, August 09-10, 2018 Madrid, Spain; Vaccines Conferences USA 2018; 27^th International Conferences on Oncology Research & Cancer Stem Cells, May 10-12, 2018 Frankfurt, Germany; Vaccines Conferences Asia 2018; 9^th International Conferences on Leukemia and Hematologic Oncology, October 05-06,2017 London, UK; 2^nd International Conferences on Epigenetics & Chromatin, November 06-08, 2017 Frankfurt, Germany; 9^th World Biomarkers Conferences, December 07-08, 2017 Madrid, Spain; Global Conferences on Oncology & Cancer, March 14-16, 2018 Singapore; Vaccines Conferences Middle East 2018; 11^th European Breast Cancer Conferences (EBCC-11), March 21-23, 2018 Barcelona, Spain; Vaccines Conferences; 35^th Annual Miami Breast Cancer Conferences, March 8-11, 2018 Florida, USA; A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments Conferences, February 1- 3, 2018, Amsterdam, Netherlands; Vaccines Conferences Canada 2018; Radiation Break-through: from DNA damage responses to precision cancer therapy Conferences, March 12 – 14, 2018 Oxford, UK; Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 4 - 6 June 2018; 25^th Biennial Conferences of the European Association for Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; Vaccines Conferences Australia; World Cancer Conferences, October 1-4 2018 Kuala Lumpur, Malaysia; Conferences on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada; ESMO 2017 Conferences-Integrating science into oncology for a better patient outcome, September 08-12 2017 Madrid, Spain

Related Societies:

Europe:

British Society for Immunology; Microbiology Society; Society for Applied Microbiology; European Society of Clinical Microbiology and Infectious Diseases

USA:

Asia and Middle-East:

Indian society of Allergy, Asthma and Clinical Immunology; Australasian Society of Clinical Immunology and Allergy; Bangladesh Society of Allergy and Immunology

Track 16: Vaccines for Pregnant Women and Neonates

Immunization during pregnancy has the potential to protect the mother and the infant against vaccine preventable diseases. New born infants are at high-risk for significant illness and death from certain infectious diseases because their immune system has not fully developed. One aim of vaccinating pregnant women is to increase the amount of maternal antibody (proteins that fight disease) transferred to infants, potentially protecting them from infectious disease.

3^rd International Conferences on Reproductive Health and Medicine, May 21-22, 2018 Vienna, Austria; Vaccines Conferences USA 2018; 4th Annual Conferences and Medicare Expo on Trauma & Critical Care, February 22-23, 2018 Paris, France; 47th Global Nursing & Healthcare Conferences, March 01-03, 2018 London, UK; 7th World Conferences on Breast Cancer, May 10-11, 2018 Frankfurt, Germany; Vaccines Conferences Asia 2018; 13^th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 27th International Conferences on Oncology Research & Cancer Stem Cells, May 10-12, 2018 Frankfurt, Germany; 28^th Euro Conferences on Cancer Science & Therapy, August 09-10, 2018 Madrid, Spain; Vaccines Conferences Middle East 2018; 11^th European Breast Cancer Conferences (EBCC-11), March 21-23, 2018 Barcelona, Spain; 35^thAnnual Miami Breast Cancer Conferences, March 8-11, 2018 Florida, USA; Vaccines Conferences; A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments Conferences, February 1- 3, 2018, Amsterdam, Netherlands; Vaccines Conferences Canada 2018; Radiation Break-through: from DNA damage responses to precision cancer therapy, March 12 – 14, 2018 Oxford, UK; Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 4 - 6 June 2018; 25^th Biennial Conferences of the European Association for Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; Vaccines Conferences Australia; World Cancer Conferences, October 1-4 2018 Kuala Lumpur, Malaysia; Conferences on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada; ESMO 2017 Conferences-Integrating science into oncology for a better patient outcome, September 08-12 2017 Madrid, Spain; 37^th Annual Pregnancy Conferences, January 23 - 28, 2017 Las Vegas, USA

Related Societies:

Europe:

USA:

Argentine Association of Allergy and Immunology; Argentine Society of Allergy and Immunology; Brazilian Society of Allergy and Immunology; Chilean Society of Allergy and Immunology

Asia and Middle-East:

Allergy & Immunology Society of Sri Lanka; Allergy and Clinical Immunology Society of Singapore; Allergy and Immunology Society of Thailand

Track 17: Vaccines for Unconventional Diseases

It is interesting to have a look on activities of drug developers in area of antibody-inducing vaccines directed against non-infectious diseases and some unconventional indications. These vaccines have been in most cases developed so far as treatment vaccines. This is in opposite to infectious diseases vaccines used as prophylactic vaccines. Despite promising late stage candidates, with some very recent failures, there is still no antibody-inducing vaccine approved targeting other than microorganism antigens (i. e targeting self-antigens , addiction molecules antigens and others. It is interesting to have a look on activities of drug developers in area of antibody-inducing vaccines directed against non-infectious diseases and some unconventional diseases.

20^th International Conferences on Neonatology and Perinatology, December 04-06, 2017 Madrid, Spain; 15^thInternational Conferences on Pediatrics and Pediatric Cardiology, February 19-20, 2018 Paris, France; 20^thInternational Conferences on Pediatrics Primary Care, September 03-04, 2018 Zurich, Switzerland; Vaccines Conferences USA 2018; 3^rd International Conferences on Pediatric Surgery, May 07-08, 2018 Frankfurt, Germany; 14^th International Conferences on Clinical Pediatrics, June 14-16, 2018 Rome, Italy; Vaccines Conferences Asia 2018; 17^th Annual Conferences on Pediatrics & Adolescent Medicine, July 09-10, 2018 Sydney, Australia; 21^st Annual Conferences on Neonatology & Pediatrics, May 30-31, 2018 Osaka, Japan; 39^th National Conferences on Pediatric Health Care National Association of Pediatric Nurse Practitioners, March 19-22, 2018 Chicago, USA; Vaccines Conferences Middle East 2018; 4^th ESCMID Conferences on Vaccines, September 8-10, 2017 Dubrovnik, Croatia; 2017 International Society for Vaccines (ISV) Annual Conferences, October 5-7, 2017 Paris, France; Vaccines Conferences Canada 2018; Vaccines R & D Conferences 2017, November 20-22, 2017, Valencia, Spain; 2^nd Global Conferences and Expo on Vaccines Research, March 19-20, 2018 London, UK; World Vaccine Conferences Washington 2018, April 3-5, 2018 Washington DC, USA; Conferences on Vaccines and Vaccination Techniques, April 16-18, 2018, Dubai, UAE; 4^th Global Conferences Virology and Vaccines, April 19-21, 2018 Valencia, Spain; Vaccines Conferences Australia; 48th National Immunization Conferences, May 15-17, 2018 Atlanta, USA; Vaccine Technology VII, June 17-22, 2018 Quebec, Canada; HIV Research for prevention Conferences (HIVR4P) October 21-25, 2018 Madrid, Spain

Related Societies:

Europe:

Swiss Society for Microbiology; Federation of European Microbiological Societies; International Society of Vaccines; International Union of Immunological Society

USA:

Ecuadorian Society of Allergy, Asthma, and Immunology; Guatemalan Allergy, Asthma and Clinical Immunology Association; Honduran Society of Allergy and Clincial Immunology

Asia and Middle-East:

Indonesian Society of Allergy and Immunology; Korean Academy of Asthma, Allergy and Clinical Immunology; Malaysian Society of Allergy and Immunology

Track 18: Animal Models and Clinical Trials

The development of human vaccines continues to rely on the use of animals for research. Regulatory authorities require novel vaccine candidates to undergo preclinical assessment in animal models before being permitted to enter the clinical phase in human subjects. Substantial progress has been made in recent years in reducing and replacing the number of animals used for preclinical vaccine research through the use of bioinformatics and computational biology to design new vaccine candidates. However, the ultimate goal of a new vaccine is to instruct the immune system to elicit an effective immune response against the pathogen of interest, and no alternatives to live animal use currently exist for evaluation of this response.

6^th World Conferences on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; Vaccines Conferences USA 2018; 29^thInternational Conferences on Vaccines and Immunization, March 19-20, 2018 London, UK ; 5^th International Conferences on HIV/AIDS, STDs and STIs, November 13-14, 2017 Las Vegas, Nevada, USA; Vaccines Conferences Asia 2018; 7^th Asia Pacific STD and Infectious Diseases Conferences, October 23-25, 2017 Osaka, Japan; 9th European Immunology Conferences, June 14-16, 2018 Rome, Italy; Vaccines Conferences Middle East 2018; 2^nd International Conferences on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; Vaccines Conferences; 11^thInternational Conferences on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; 22^nd International AIDS Conferences (AIDS 2018) July 23-27 2018 Amsterdam, Netherlands; CHA 2018; Vaccines Conferences Canada 2018; 20^thInternational Conferences on HIV and AIDS, May 14 - 15, 2018 London, UK; The annual Conferences on Retroviruses and Opportunistic Infections (CROI), March 4 -7, 2018 Massachusetts, USA; 12^th Annual ACTHIV, April 5 - 7, 2018, Chicago, USA; 20^th Bangkok International Symposium on HIV Medicine 2018, January 17 - 19, 2018, Bangkok, Thailand; 2^ndInternational Conferences on Healthy Living for HIV Infected Individuals, September 01-02, 2017 Barcelona, Spain; 21^stAnnual United States Conferences on AIDS (USCA), September 07-09, 2017 Washington, DC, USA; Vaccines Conferences Australia; European Conferences on Healthy Living with HIV, September 15-16, 2017 Barcelona, Spain; 16^th European AIDS Conferences, October 25-28, 2017 Mila, Italy; Australasian AIDS Conferences 2017, November 06-08, 2017 Canberra, Australia; ICASA 2017: International Conferences on AIDS and STIs in Africa (ICASA), December 04-09, 2017; Côte d’Ivoire, West Africa

Related Societies:

Europe:

USA:

Asia and Middle-East:

Philippine Society of Allergy, Asthma and Immunology; Taiwan Academy of Pediatric Allergy Asthma Immunology; Vietnam Association of Allergy, Asthma and Clinical Immunology

Track 19: Animal & Plant Derived Vaccines

It has been about 30 years since the first plant engineering technology was established. Although the concept of plant-based pharmaceuticals or vaccines motivates us to develop practicable commercial products using plant engineering, there are some difficulties in reaching the final goal: to manufacture an approved product. At present, the only plant-made vaccine approved by the United States Department of Agriculture is a Newcastle disease vaccine for poultry that is produced in suspension-cultured tobacco cells. The progress toward commercialization of plant-based vaccines takes much effort and time, but several candidate vaccines for use in humans and animals are in clinical trials. This review discusses plant engineering technologies and regulations relevant to the development of plant-based vaccines and provides an overview of human and animal vaccines currently under clinical trials.

28^th Euro Conferences on Cancer Science & Therapy, August 09-10, 2018 Madrid, Vaccines Conferences USA 2018; Spain; 27^th International Conferences on Oncology Research & Cancer Stem Cells, May 10-12, 2018 Frankfurt, Germany; Vaccines Conferences Asia 2018; 9^th International Conferences on Leukemia and Hematologic Oncology, October 05-06,2017 London, UK; 2^nd International Conferences on Epigenetics & Chromatin, November 06-08, 2017 Frankfurt, Germany; Vaccines Conferences Middle East 2018; 9^th World Biomarkers Conferences, December 07-08, 2017 Madrid, Spain; Global Conferences on Oncology & Cancer, March 14-16, 2018 Singapore;11^th European Breast Cancer Conferences (EBCC-11), March 21-23, 2018 Barcelona, Spain; Vaccines Conferences; 35^th Annual Miami Breast Cancer Conferences, March 8-11, 2018 Florida, USA; A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments Conferences, February 1- 3, 2018, Amsterdam, Netherlands; Vaccines Conferences Canada 2018; Radiation Break-through: from DNA damage responses to precision cancer therapy Conferences, March 12 – 14, 2018 Oxford, UK; Molecular Pathology Approach to Cancer, Amsterdam, Netherlands, 4 - 6 June 2018; 25^th Biennial Conferences of the European Association for Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; World Cancer Conferences, October 1-4 2018 Kuala Lumpur, Malaysia; Vaccines Conferences Australia; Conferences on Cancer Immunotherapy: Combinations (C5), March 23-27, 2018, Québec, Canada; ESMO 2017 Conferences-Integrating science into oncology for a better patient outcome, September 08-12 2017 Madrid, Spain

Related Societies:

Europe:

USA:

American Association of Immunologists; American Association of Pharmaceutical Scientists; American Association of Veterinary Immunologists; American Society for Histocompatibility and Immunogenetics

Asia and Middle-East:

Track 20: Vectors, Adjuvants & Delivery Systems

A vaccine adjuvant is an ingredient of a vaccine that helps create a stronger immune response in the patient’s body. In other words, adjuvants help vaccines work better. Some vaccines made from weakened or dead germs contain naturally occurring adjuvants and help the body produce a strong protective immune response. However, most vaccines developed today include just small components of germs, such as their proteins, rather than the entire virus or bacteria. These vaccines often must be made with adjuvants to ensure the body produces an immune response strong enough to protect the patient from the germ he or she is being vaccinated against. Aluminum gels or aluminum salts are vaccine ingredients that have been used in vaccines since the 1930s. Small amounts of aluminum are added to help the body build stronger immunity against the germ in the vaccine. Aluminum is one of the most common metals found in nature and is present in air, food, and water. The amount of aluminum present in vaccines is low and is regulated by the U.S. Food and Drug Administration (FDA).

10^th International Virology Conferences and Expo, July 02-04, 2018 Vienna, Austria; Vaccines Conferences USA 2018; 8^th Global Conferences on Microbiology & Infectious Diseases, February 22-23, 2018 Paris, France; 16^th International Pharmaceutical Microbiology and Biotechnology Conferences, May 21-23, 2018 Vienna, Austria; Vaccines Conferences Asia 2018; 4^th World Conferences and Expo on Applied Microbiology, November 29-December 01, 2017 Madrid, Spain; 8^th Clinical Microbiology Conferences, October 26-28, 2017 Paris, France; 46^th World Conferences on Microbiology, September 18-19, 2017 Dublin, Ireland; 13th World Conferences on Healthcare & Technologies, June 14-15, 2018 Dublin, Ireland; British Society for Immunology Conferences 2017, December 04-07, 2017 Brighton, UK; Vaccines Conferences Middle East 2018; Keystone Symposium: Conferences on Cancer Immunotherapy: Combinations, March 23-27, 2018 Montreal, Canada; Vaccines Conferences; Keystone Symposium on HIV and Co-infections: Pathogenesis, Inflammation and Persistence, April 15-19 2018 Whistler, Canada; Vaccines Conferences Canada 2018; Immunochemistry and Immunobiology Conferences, June 10-15, 2018 West Dover, USA; Mechanisms in Immunity and Autoimmunity Conferences, June 17-21, 2018 Dresden, Germany; Gordon Research Conferences: Cell Death, August 05–10, 2018 Newry, USA; 25^th Biennial Conferences of the European Association for Cancer Research, 30-03 July 2018 Amsterdam, Netherlands; World Cancer Conferences, October 1-4 2018 Kuala Lumpur, Malaysia; Vaccines Conferences Australia; ESMO 2017 Conferences-Integrating science into Oncology Conference for a better patient outcome, September 08-12 2017 Madrid, Spain; 37^th Annual Pregnancy Conferences, January 23 - 28, 2017 Las Vegas, USA

Related Societies:

Europe:

European Society for Immunodeficiency; French Society of Immunology ; Immunology of Diabetes Society; Deutsche Gesellschaft für Immunologie

USA:

Asia and Middle-East:

Track 21: Vaccine Production & Development

Vaccine development is an activity that focuses on a variety of technological initiatives and applied research, which enhance and promote improved systems and practices for vaccine safety. In the past year, the unprecedented Ebola disease outbreak galvanized research and industry response and as we continue to search for solutions, we must review the lessons learned in order to overcome the current challenges. Vaccine development is a long, complex process, often lasting 10-15 years and involving a combination of public and private involvement. The current system for developing, testing, and regulating vaccines developed during the 20th century as the groups involved standardized their procedures and regulations.

29^th International Conferences on Vaccines and Immunization, March 19-20, 2018 London, UK; Vaccines Conferences USA 2018; 9th Molecular Immunology & Immunogenetics Conferences, March 08-09, 2018 London, UK; 9^th European Immunology Conferences, June 14-16, 2018 Rome, Italy; Vaccines Conferences Asia 2018; 2^nd International Conferences on Autoimmunity, November 06-07, 2017 Frankfurt, Germany; 11^th International Conferences on Allergy, Asthma & Clinical Immunology, September 07-08, 2017 Edinburgh, Scotland; 5^th International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; Vaccines Conferences Middle East 2018; International Conferences on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; 6^thWorld Conferences on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; Vaccines Conferences Canada 2018; 4^th ESCMID Conferences on Vaccines, September 8-10, 2017 Dubrovnik, Croatia; 2017 International Society for Vaccines (ISV) Annual Conferences, October 5-7, 2017 Paris, France; Vaccines Research & Development Conferences 2017, November 20-22, 2017, Valencia, Spain; Vaccines Conferences; 2^nd Global Conferences on Vaccines Research, March 19-20, 2018 London, UK; World Vaccine Conferences Washington 2018, April 3-5, 2018 Washington DC, USA; Vaccines Conferences Australia; Global Conferences on Vaccines and Vaccination Techniques, April 16-18, 2018, Dubai, UAE; 4^th Global Conferences on Virology and Vaccines, April 19-21, 2018 Valencia, Spain; 48^th National Immunization Conferences, May 15-17, 2018 Atlanta, USA; Vaccines Technology Conferences VII, June 17-22, 2018 Quebec, Canada; HIV Research for prevention Conferences (HIVR4P) October 21-25, 2018 Madrid, Spain

Related Societies:

Europe:

European Academy of Allergy and Clinical Immunology (EAACI); European Molecular Biology Laboratory (EMBL); Medical Research Council (MRC)

USA:

Asia and Middle-East:

Russian Association of Allergology and Clinical Immunology; Turkish National Society of Allergy and Clinical Immunology; Ukrainian Association of Allergologists and Clinical Immunologists

Track 22: Cellular Immunology and Latest Innovations

The response to pathogens is composed by the complex interactions and activities of the large number of diverse cell types involved in the immune response. The innate immune response is the first line of defence and occurs soon after pathogen exposure. It is carried out by phagocytic cells such as neutrophils and macrophages, cytotoxic natural killer (NK) cells, and granulocytes. The subsequent adaptive immune response includes antigen-specific defence mechanisms and may take days to develop. Cell types with critical roles in adaptive immunity are antigen-presenting cells including macrophages and dendritic cells. Antigen-dependent stimulation of various cell types including T cell subsets, B cells, and macrophages all play critical roles in host defence.

6^th Euro-Global Conferences on Infectious Diseases, September 7-9, 2017 Paris, France; Vaccines Conferences USA 2018; 5^th International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; 4^th World Conferences on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; International Conferences on Emerging Infectious Diseases, 31^st August-1^st September 2018 Zurich, Switzerland; Vaccines Conferences Asia 2018; 6^th World Conferences on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 13^th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 7^th Asia Pacific STD and Infectious Diseases Conferences, October 23-25, 2017 Osaka, Japan; Vaccines Conferences; 3^rd International Conferences on Flu and Emerging Infectious Diseases, November 06-07, 2017 Las Vegas, Nevada, USA; Vaccines Conferences Middle East 2018; 18^th International Conferences on Infectious Diseases, March 1-4, 2018 Buenos, Argentina; The European Conferences of Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; ICID 2018 : 20^th International Conferences on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Twelfth Annual Conferences on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; Vaccines Conferences Canada 2018; 30^th Annual Infectious Diseases in Children Symposium, November 18-19, 2017 New York, USA; Conferences on Infectious Diseases: Adult Issues in the Outpatient and Inpatient Settings, April 02-06, 2018 Florida, USA; Vaccines Conferences Australia; ID Week 2017 Infectious Diseases Society of America Conferences(IDSA), October 4-7, 2017 California, USA; 10^th World Conferences of the World Society of Pediatric Infectious Diseases(WSPID), December 2-5, 2017 Shenzhen, China

Related Societies:

Europe:

USA:

Asia and Middle-East:

Track 23: Antibodies Engineering and Therapeutics

Antibodies, also called immunoglobulins, are large Y-shaped proteins which function to identify and help remove foreign antigens or targets such as viruses and bacteria. Antibodies are produced by specialized white blood cells called B lymphocytes (or B cells). When an antigen binds to the B-cell surface, it stimulates the B cell to divide and mature into a group of identical cells called a clone. The mature B cells, called plasma cells, secrete millions of antibodies into the bloodstream and lymphatic system. Every different antibody recognizes a specific foreign antigen. This is because the two tips of its “Y” are specific to each antigen, allowing different antibodies to bind to different foreign antigens. Antibodies are produced by the immune system in response to the presence of an antigen. Antibody engineering has become a well-developed discipline, encompassing discovery methods, production strategies, and modification techniques that have brought forth clinically investigated and marketed therapeutics. The realization of the long-standing goal of production of fully human monoclonal antibodies has focused intensive research on the clinical employment of this potent drug category.

5th International Conferences on Infectious Diseases, March 1-2, 2018 Berlin, Germany; Vaccines Conferences USA 2018; 4th World Conferences on Rare Diseases and Orphan Drugs, June 11-12, 2018 Dublin, Ireland; International Conferences on Emerging Infectious Diseases, 31st August-1st September 2018 Zurich, Switzerland; Vaccines Conferences Asia 2018; 6^th World Conferences on Control and Prevention of HIV/AIDS, STDs & STIs, October 29-30 Madrid, Spain; 13^th World Conferences on Infection Prevention and Control, December 14-16, 2017 Rome, Italy; 6^th Euro-Global Conferences on Infectious Diseases, September 7-9, 2017 Paris, France; 3rd International Conferences on Influenza and Zoonotic Diseases, August 21-22, 2017 Birmingham, UK; Vaccines Conferences Middle East 2018; 18^thInternational Conferences on Infectious Diseases, March 1-4, 2018 Buenos, Argentina; The European Conferences of Clinical Microbiology and Infectious Diseases, April 21-24, 2018 Madrid, Spain; Vaccines Conferences Canada 2018; ICID 2018; 20th International Conferences on Infectious Diseases, January 29-30, 2018 Sydney, Australia; Vaccines Conferences; Twelfth Annual Conferences on Infectious Diseases Update for Primary Care and Hospital Medicine, September 14-15, 2017 Baltimore, USA; 30^th Annual Conferences on Infectious Diseases in Children, November 18-19, 2017 New York, USA; Conferences on Infectious Diseases: Adult Issues in the Outpatient and Inpatient Settings, April 02-06, 2018 Florida, USA; Vaccines Conferences Australia; ID Week 2017 Infectious Diseases Society of America Conferences (IDSA), October 4-7, 2017 California, USA; 10^th World Conferences of the World Society of Pediatric Infectious Diseases (WSPID), December 2-5, 2017 Shenzhen, China

Related Societies:

Europe:

European Society for Immunodeficiency; French Society of Immunology ; Immunology of Diabetes Society; Deutsche Gesellschaft für Immunologie

USA:

Asia and Middle-East:

Track 24: Current Research & Future Challenges

Vaccine development remains challenging because of the highly sophisticated evasion mechanisms of pathogens for which vaccines are not yet available. Recent years have witnessed both successes and failures of novel vaccine design and the strength of iterative approaches is increasingly appreciated. These combine discovery of novel antigens, adjuvants and vectors in the preclinical stage with computational analyses of clinical data to accelerate vaccine design. Reverse and structural vaccinology have revealed novel antigen candidates and molecular immunology has led to the formulation of promising adjuvants. Gene expression profiles and immune parameters in patients, vaccines and healthy controls have formed the basis for bio-signatures that will provide guidelines for future vaccine design.

20^th International Conferences on Neonatology and Perinatology, December 04-06, 2017 Madrid, Spain; Vaccines Conferences USA 2018; 15^thInternational Conferences on Pediatrics and Pediatric Cardiology, February 19-20, 2018 Paris, France; 20^thInternational Conferences on Pediatrics Primary Care, September 03-04, 2018 Zurich, Switzerland; Vaccines Conferences Asia 2018; 3^rd International Conferences on Pediatric Surgery, May 07-08, 2018 Frankfurt, Germany; 14^th International Conferences on Clinical Pediatrics, June 14-16, 2018 Rome, Italy; Vaccines Conferences; 17^th Annual Conferences on Pediatrics & Adolescent Medicine, July 09-10, 2018 Sydney, Australia; 21^st Annual Conferences on Neonatology & Pediatrics, May 30-31, 2018 Osaka, Japan; Vaccines Conferences Middle East 2018; 39^th National Conferences on Pediatric Health Care National Association of Pediatric Nurse Practitioners, March 19-22, 2018 Chicago, USA; 4^th ESCMID Conferences on Vaccines, September 8-10, 2017 Dubrovnik, Croatia; 2017 International Society for Vaccines (ISV) Annual Conferences, October 5-7, 2017 Paris, France; Vaccines Conferences Canada 2018; Vaccines R & D Conferences 2017, November 20-22, 2017, Valencia, Spain; 2^nd Global Conferences and Expo on Vaccines Research, March 19-20, 2018 London, UK; World Vaccine Conferences Washington 2018, April 3-5, 2018 Washington DC, USA; Conferences on Vaccines and Vaccination Techniques, April 16-18, 2018, Dubai, UAE; 4^th Global Conferences Virology and Vaccines, April 19-21, 2018 Valencia, Spain; Vaccines Conferences Australia; 48th National Immunization Conferences, May 15-17, 2018 Atlanta, USA; Vaccine Technology VII, June 17-22, 2018 Quebec, Canada; HIV Research for prevention Conferences (HIVR4P) October 21-25, 2018 Madrid, Spain

Related Societies:

Europe:

European Academy of Paediatrics; European Malaria Foundation (e-malaria Foundation); European Malaria Vaccine Development (EUROMALVAC); European malaria Vaccine Initiative (EMVI)

USA:

Autism Science Foundation (ASF); Childhood Influenza Immunization Coalition (CIIC); Edward Jenner Vaccine Society; Global Polio Eradication Initiative

Asia and Middle-East:

Lebanese Society of Allergy and Immunology; Moldavian Society of Allergology & Immunology; Moroccan Society of Allergology and Clinical Immunology

29th International Conference on Vaccines and Immunization

Theme: Highlights of latest technologies and innovations in Vaccines and Immunization

Immunization/Vaccination is a major pasture in eradication of diseases. Conventional approaches to vaccine draft were to enfeeble the human pathogen, Vaccinology is the science of vaccine evolution and how the immune system responds to vaccines, and additionally it includes perpetual workup of Immunization programs, vaccine safety and its efficacy.

Vaccination is important and effective way of preventing infectious disease. That is why majority of countries in the world adopted in second half of the twentieth century to implement various immunization programs. Effectiveness of vaccination is unambiguously proven by regression up-to clearance of many diseases preventable by vaccination. Influence of vaccination can be best illustrated on eradication of smallpox in the world. Thanks to vaccination this deadly disease was overcome, in seventies of the last century this disease was the cause of many deaths. In countries with low immunization rate, i.e. with not adequate collective immunity, many vaccination preventable diseases occur.

Vaccines Summit 2018 piles up all the Researchers and Healthcare professionals under one roof of to talk on the current research/public health programs and their scientific progress.

Importance & Scope:

Conference series invites all professionals around the world to attend “29^th International Conference on Vaccines and Immunization” features with theme "Highlights of latest technologies and innovations in Vaccines and Immunization" on March 19-20, 2018 in London, UK. This conference brings a novel and International compound of massive and form cognizance on vaccines and vaccination, leading universities stir up the conference, an ideal dais to quantify out proficiency, enrich collaborations across trade and world, and assess upgrading technologies across the world.

For more Details: vaccines-immunization.conferenceseries.com

Why London?

London is the capital and most populous city of England and the United Kingdom. London is a leading global city, in the arts, commerce, education, entertainment, fashion, finance, healthcare, media, professional services, research and development, tourism, and transport. It is one of the world’s leading financial centres and has the fifth- or sixth-largest metropolitan area GDP in the world.

This City is the world cultural capital. It is the world’s most-visited city as measured by international arrivals and has the world’s largest city airport system measured by passenger traffic. London’s universities form the largest concentration of higher education institutes in Europe, and a 2014 report placed it first in the world university rankings. According to the report London also ranks first in the world in software, multimedia development and design, and shares first position in technology readiness.

This city has the greatest concentration of top class universities in the world and its international student population of around 110,000 is larger than any other city in the world. London is home to five major medical schools – Barts and The London School of Medicine and Dentistry, King’s College London School of Medicine (the largest medical school in Europe), Imperial College School of Medicine, UCL Medical School and St George’s, University of London – and has a large number of affiliated teaching hospitals. It is also a major centre for biomedical research, and three of the UK’s eight academic health science centres are based in the city – Imperial College Healthcare, King’s Health Partners and UCL Partners (the largest such centre in Europe).

The presence of universities, hospitals, labs and other professional services, together with key installations of the U.K. make it favourite destination for scientific meetings.

Major Hospitals
London	United Kingdom	Worldwide
Barts Health NHS Trust	Addenbrooke's Hospital	Stanford Hospitals and Clinics
Barts Health NHS Trust	King's Mill Hospital	Oxford Medical School
Evelina Children's Hospital - St Thomas' Hospital	Nottingham University Hospitals	Mayo Clinic Scottsdale AZ
Royal London Hospital	St Thomas' Hospital	University of Maryland Medical Center
St Mary's Hospital	Papworth Hospital	University of Texas Cancer Centre
St. George's Hospital, London	Royal Devon and Exeter Hospital	Harvard Medical School
The Institute of Cancer Research	King's College Hospital	Cleveland Clinic

Major Vaccines Associations and Societies
London	Europe	Worldwide
Vaccine Research Association	European Federation of Immunological societies (EFIS)	The International Union of Immunological Societies
Vaccine Research Association	Italian Society of Allergy, Asthma and Clinical Immunology	The Society for Mucosal Immunology
British Society for Immunology	German Society for Allergology and Clinical Immunology	British Society for Immunology
British Society for Immunology	British Society of Allergy and Clinical Immunology	Federation of African Immunological Societies
Child Health and Society	French Society of Allergology and Clinical Immunology	Federation of Clinical Immunology Societies
Child Health and Society	Dutch Society of Allergology	Infectious Diseases Society of America
British Global and Travel Health Association	Romanian Society of Allergology and Clinical Immunology	Immune Deficiency Foundation
British Global and Travel Health Association	Czech Society of Allergology and Clinical Immunology	European Federation of Immunological Societies

Industries Associated with Vaccines
London	United Kingdom	Worldwide
Cambridge Healthcare Supplies Ltd	GlaxoSmithKline	MSD (Merck)
DiscoveRx	AstraZeneca (Med Immune)	Pfizer
Novartis	Pfizer UK	Vaxon Biotech
Parexel	Oxford BioMedica	Sanofi
Praxisb Unico	Vectura Group	Sinovac Biotech
The Binding Site	Proximagen	Vaxxas Nanopatch
The Jenner Institute	Hikma Pharmaceuticals	Antitope (Abzena)
Treos Bio	AAH Pharmaceuticals	GlaxoSmithKline

Universities Associated with Vaccine Research
London	United Kingdom	Worldwide
Aston University	Heriot-Watt University	Stanford University
Kingston University	Kingston University	The University of Sydney
London City University	Surrey Clinical Research Centre	University of Cambridge
Newman University	University College London	Johns Hopkins University
University of London	Oxford University	Harvard University
University of Oxford	University of East Anglia	University of California
University of Alabama	St George's University of London	University of Oxford

Market Value and Market Growth on Vaccines Research in the Past and Upcoming 10 Years:

The global vaccine market is one of the fastest growing segments and new predictions estimate the value of the market to reach between $48 billion and more than $70 billion over the next five to eight years.

According to a new report released by Transparency Market Research, the value of the global human vaccines market is expected to grow from a $28.3 billion in 2015 to $72.5 billion in 2024. The projection would represent a compound annual growth rate (CAGR) of 11.2% from 2016 to 2024. Even though the dollar figure is large and growing, vaccines still only account 3% of the market share within the global pharmaceutical industry. The report broke down expectations by segments. By age group, paediatric vaccines accounted for 57.5% of the share in 2015, but adult vaccines are expected to grow at a 13.2% CAGR during the forecast period. When the research group analysed the market by product, they found the pneumococcal segment to have the majority share in 2015, but expect hepatitis products to demonstrate strong growth through 2024. By vaccine type, the conjugate vaccines held the majority share in 2015, but the combination vaccines were expected to have the largest CAGR.

Estimated Impact of Immunization on Vaccines Preventable Diseases (WHO Report):

Funding for Vaccines Research:

United Kingdom:

In 2007, the Medical Research Council reviewed its vaccine research portfolio and concluded that it needed to strengthen its translational research by accelerating basic vaccine research into product development and clinical practice and using vaccine research to inform immunisation policies. Five projects have received funding, including a study to monitor the effectiveness of HPV vaccines in teenage girls. There are some academic centres which focus on vaccine research. Some, such as the Jenner Institute in Oxford, specialise in researching novel candidate vaccines. The limiting step for such institutes is the expense of producing batches of novel vaccines and testing them in clinical trials. In 2005, in an effort to encourage UK based pharmaceutical manufacture (including vaccines) the government invested £30m in establishing a National Bio-manufacturing Centre. This facility can produce a wide variety of biopharmaceuticals (including vaccines) under contract from the private sector and academia.

Global Funds:

· United Nations Children’s Fund (UNICEF)

· Centre for Disease Control and Prevention (CDC)

· Bill and Melinda Gates Foundation

· American Academy of Paediatrics (AAP)

· Vaccine Foundation (V Foundation)

· Rockefeller Foundation (RF)

· National Institute of Health (NIH)

· Children’s Vaccine Initiative (CVI)

· Global Alliance for Vaccines and Immunization (GAVI)

Top 10 pharmaceutical companies based on global vaccine revenues in 2015 and 2022 (in million U.S. dollars):

Target Audience:

The conference discusses the latest research outcomes and technological advancements in the field and brings together leading Paediatrics, Immunologists, Physicians, Research Scholars, Students along with Industrial and Vaccines Research professionals to exchange share their views on critical aspects of Vaccines research. The event is designed in a way to provide an exclusive platform for new researchers, scholars and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the field of Vaccination. Vaccines summit 2018 will comprise leading keynote speakers, session speakers, poster presenters who will be presenting their research on the topics Human Vaccines Against Infectious Diseases, Cancer, Malaria and TB Vaccines, Immunizations and Bioterrorism, Combination and Conjugate Vaccines, DNA and Synthetic Vaccines, Live, Attenuated, Inactivated and Subunit Vaccines, Travel and Edible vaccines, Paediatric Vaccination, Vaccines for Immune mediated Diseases, Veterinary Vaccines, Vaccines against drugs‎, Vaccines and Autism, Vaccine Safety and Efficacy, Geriatric Immunization, Vaccines for Pregnant women and Neonates, Immunology and Animal Models, Animal and Plant Derived Vaccines, Vectors, Adjuvants and Delivery Systems, Vaccines for unconventional diseases, Cellular Immunology and Latest Innovations, Clinical Immunology & Cancer Immunotherapy, Molecular and Structural Immunology, Antibodies: Engineering and Therapeutics, Regulatory, Societal and Legislation Aspects of Vaccines etc.

Projections:

The global market for vaccines has reported an impressive development in its market valuation, thanks to the increasing rate of birth globally. The rising incidence of diseases such as polio, influenza, hepatitis has also fuelled demand from the global paediatric vaccines market to a great extent.

The vaccines segment dominates the global vaccine products market. The market for live attenuated vaccines has registered the highest growth among all the segments, based on technology. By diseases, the infectious diseases segment has occupied the leading position at present. However, the rising prevalence of cancer, specifically Leukaemia, in kids is projected to register the fastest growth in this market in the coming years. This will further boost the global market for vaccines in the near future.

North America leads the global market for vaccines and is closely followed by Europe. However, the market for vaccines in Asia Pacific is likely to report the fastest growth during the period from 2012 to 2018 owing to the high birth rate in China and India.

Though the growth prospects for the global market for vaccines looks lucrative, low accessibility to vaccines in developing economies, together with strict regulations for the usage of these vaccines, is likely to hamper the growth of this market over the next few years.

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	March 19-20, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1	Day 2
Poster Opportunity Closed	Click Here to View